TGFB1 and cancer: Key cellular contributors include cancer-associated fibroblasts (CAFs), which deposit dense extracellular matrix (ECM) and secrete pro-survival cytokines (e.g., TGF-β, HGF, IL-6), thereby enhancing drug resistance via PI3K/AKT and MAPK pathways [120].